From Wikipedia, the free encyclopedia
MMB-CHMICA Other names AMB-CHMICA Legal status
CA : Schedule II
DE : NpSG (Industrial and scientific use only)
UK : Under Psychoactive Substances Act
US : Schedule I
Methyl N -{[1-(cyclohexylmethyl)-1H -indol-3-yl]carbonyl}-L -valinate
CAS Number ChemSpider UNII CompTox Dashboard (EPA ) Formula C 22 H 30 N 2 O 3 Molar mass 370.493 g·mol−1 3D model (JSmol )
CC(C)[C@@H](C(=O)OC)NC(=O)c1cn(c2c1cccc2)CC3CCCCC3
InChI=1S/C22H30N2O3/c1-15(2)20(22(26)27-3)23-21(25)18-14-24(13-16-9-5-4-6-10-16)19-12-8-7-11-17(18)19/h7-8,11-12,14-16,20H,4-6,9-10,13H2,1-3H3,(H,23,25)/t20-/m0/s1
Key:ROWZIXRLVUOMCJ-FQEVSTJZSA-N
MMB-CHMICA (AMB-CHMICA ) is a designer drug and synthetic cannabinoid .[1] [2] In 2018, it was the sixth-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Administration .[3]
References [ ]
^ Göl E, Çok I (January 2019). "New psychoactive substances in Turkey: Narcotics cases assessed by the Council of Forensic Medicine between 2016 and 2017 in Ankara, Turkey". Forensic Science International . 294 : 113–123. doi :10.1016/j.forsciint.2018.11.003 . PMID 30502695 .
^ Mardal M, Dalsgaard PW, Qi B, Mollerup CB, Annaert P, Linnet K (April 2018). "E". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences . 1083 : 189–197. doi :10.1016/j.jchromb.2018.03.016 . PMID 29549742 .
^ "Emerging Threat Report: Annual 2018" (PDF) . Special Testing and Research Laboratory, Drug Enforcement Administration.
Cannabinoids
Phytocannabinoids
Cannabichromenes Cannabicyclols Cannabidiols Cannabielsoins Cannabigerols Cannabinols and cannabinodiols Cannabitriols Delta-8-tetrahydrocannabinols Delta-9-tetrahydrocannabinols
Delta-9-THC (THC)
THCH
THCP
THCV
Miscellaneous cannabinoids Active metabolites
Endocannabinoids
Arachidonoyl ethanolamide (AEA; anandamide)
2-Arachidonoylglycerol (2-AG)
2-Arachidonyl glyceryl ether (2-AGE; noladin ether)
2-Oleoylglycerol (2-OG)
N-Arachidonoyl dopamine (NADA)
N-Arachidonylglycine (NAGly)
N-Arachidonoyl serotonin (AA-5-HT)
Docosatetraenoylethanolamide (DEA)
Lysophosphatidylinositol (LPI)
Oleamide
Oleoylethanolamide (OEA)
Palmitoylethanolamide (PEA)
RVD-Hpα
Stearoylethanolamide (SEA)
O-Arachidonoyl ethanolamine (O-AEA; virodhamine)
Synthetic cannabinoid receptor agonists / neocannabinoids
Classical cannabinoids (dibenzopyrans) Non-classical cannabinoids Adamantoylindoles Benzimidazoles Benzoylindoles Cyclohexylphenols Eicosanoids Hydrocarbons Indazole carboxamides Indazole-3- carboxamides Indole-3-carboxamides Indole-3-carboxylates Naphthoylindazoles Naphthoylindoles Naphthoylpyrroles Naphthylmethylindenes Naphthylmethylindoles Phenylacetylindoles Pyrazolecarboxamides Pyrrolobenzoxazines Quinolinyl esters Tetramethylcyclo- propanoylindazoles Tetramethylcyclo- propanoylindoles
A-796,260
A-834,735
FUB-144
UR-144
XLR-11
XLR-12
Tetramethylcyclo- propylindoles Others
Allosteric CBR ligands Endocannabinoid enhancers (inactivation inhibitors) Anticannabinoids (antagonists/inverse agonists/antibodies)
See also: Cannabinoid receptor modulators (cannabinoids by pharmacology)
List of: AM cannabinoids
JWH cannabinoids
Designer drugs § Synthetic cannabimimetics
Categories :
Indolecarboxamides Cannabinoids Cyclohexyl compounds Methyl esters Carboxylate esters Hidden categories:
Articles without EBI source Chemical pages without DrugBank identifier Articles without KEGG source Drugs missing an ATC code Articles containing unverified chemical infoboxes